"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
1
Ep167: Leslie Williams on transfer RNA therapies
1:11:28
1:11:28
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.De către Timmerman Report
…
continue reading
1
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
1:03:35
1:03:35
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.De către Timmerman Report
…
continue reading
1
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
1:02:45
1:02:45
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.De către Timmerman Report
…
continue reading
1
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
56:39
56:39
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
56:39
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.De către Timmerman Report
…
continue reading
1
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
1:08:19
1:08:19
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.De către Timmerman Report
…
continue reading
1
Ep162: Sean McClain on AI for Biologic Drug Discovery
1:05:59
1:05:59
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:05:59
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.De către Timmerman Report
…
continue reading
1
Ep161: Jeff Stein on a Long-Lasting Flu Drug
1:08:51
1:08:51
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:08:51
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.De către Timmerman Report
…
continue reading
1
Ep160: Abe Ceesay on Precision Neuroscience
1:08:48
1:08:48
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:08:48
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.De către Timmerman Report
…
continue reading
1
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
1:07:22
1:07:22
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:07:22
Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.De către Timmerman Report
…
continue reading
1
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
1:00:44
1:00:44
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:00:44
David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.De către Timmerman Report
…
continue reading
1
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
56:33
56:33
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.De către Timmerman Report
…
continue reading
1
Ep156: David Liu on New Tools and Techniques for Biology
1:52:57
1:52:57
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.De către Timmerman Report
…
continue reading
1
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
1:02:37
1:02:37
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:02:37
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.De către Timmerman Report
…
continue reading
1
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
1:03:14
1:03:14
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:14
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.De către Timmerman Report
…
continue reading
1
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
1:01:43
1:01:43
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:01:43
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.De către Timmerman Report
…
continue reading
1
Ep152: Jens Eckstein on Investing in Healthy Aging
1:05:05
1:05:05
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:05:05
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.De către Timmerman Report
…
continue reading
1
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
1:03:55
1:03:55
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:55
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.De către Timmerman Report
…
continue reading
1
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
1:03:48
1:03:48
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:48
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.De către Timmerman Report
…
continue reading
1
Ep149: Nancy Stagliano on Precision Neuroscience
1:01:53
1:01:53
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:01:53
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.De către Timmerman Report
…
continue reading
1
Ep148: Diana Brainard on the Fight Against Infectious Disease
1:03:27
1:03:27
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:27
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.De către Timmerman Report
…
continue reading
1
Ep147: Reid Huber on Investing in the Future of Medicine
1:08:41
1:08:41
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:08:41
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.De către Timmerman Report
…
continue reading
1
Ep146: Jeff Huber on Life in Tech and Biotech
1:47:05
1:47:05
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:47:05
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.De către Timmerman Report
…
continue reading
1
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
1:06:39
1:06:39
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:06:39
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.De către Timmerman Report
…
continue reading
1
Ep144: Turning the Tables, Rob Perez Interviews Me
1:04:58
1:04:58
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:04:58
Turning the Tables, Rob Perez Interviews MeDe către Timmerman Report
…
continue reading
1
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
1:10:25
1:10:25
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:10:25
Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech FoundersDe către Timmerman Report
…
continue reading
1
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
55:54
55:54
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
55:54
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.De către Timmerman Report
…
continue reading
1
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
1:09:30
1:09:30
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:09:30
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.De către Timmerman Report
…
continue reading
1
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
1:02:40
1:02:40
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:02:40
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.De către Timmerman Report
…
continue reading
1
Ep139: Kevin Conroy on Early Detection of Cancer
1:08:28
1:08:28
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:08:28
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.De către Timmerman Report
…
continue reading
1
Ep138: Jodie Morrison on Becoming a Biotech CEO
1:00:17
1:00:17
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:00:17
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.De către Timmerman Report
…
continue reading
1
Ep137: Aaron Ring on Immunotherapy for Cancer & More
56:37
56:37
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
56:37
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.De către Timmerman Report
…
continue reading
1
Ep136: Deborah Palestrant on Building Biotech Startups
52:52
52:52
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
52:52
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.De către Timmerman Report
…
continue reading
1
Ep135: John Maraganore on Developing a New Class of Medicines
1:03:51
1:03:51
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:51
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.De către Timmerman Report
…
continue reading
1
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
1:16:22
1:16:22
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:16:22
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.De către Timmerman Report
…
continue reading
1
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
1:10:33
1:10:33
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:10:33
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.De către Timmerman Report
…
continue reading
1
Ep132: Eric Dobmeier on Treating Kidney Disease
1:05:44
1:05:44
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:05:44
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.De către Timmerman Report
…
continue reading
1
Ep131: Ryan Watts on Neuroscience Drug R&D
1:05:32
1:05:32
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:05:32
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.De către Timmerman Report
…
continue reading
1
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
1:09:29
1:09:29
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:09:29
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.De către Timmerman Report
…
continue reading
1
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
1:11:43
1:11:43
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:11:43
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.De către Timmerman Report
…
continue reading
1
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
1:00:34
1:00:34
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:00:34
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.De către Timmerman Report
…
continue reading
1
Ep127: Jeb Keiper on Computational Drug Discovery
1:09:41
1:09:41
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:09:41
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.De către Timmerman Report
…
continue reading
1
Ep126: DA Wallach on Becoming a Biotech VC
1:11:38
1:11:38
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:11:38
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.De către Timmerman Report
…
continue reading
1
Ep125: Barry Greene on a New Drug for Depression
1:04:52
1:04:52
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:04:52
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.De către Timmerman Report
…
continue reading
1
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
1:09:53
1:09:53
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:09:53
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.De către Timmerman Report
…
continue reading
1
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
1:15:26
1:15:26
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:15:26
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.De către Timmerman Report
…
continue reading
1
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
1:00:04
1:00:04
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:00:04
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.De către Timmerman Report
…
continue reading
1
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
1:03:49
1:03:49
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:03:49
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.De către Timmerman Report
…
continue reading
1
Ep120: Tim Lu on Gene Circuits for Cell Therapy
1:04:14
1:04:14
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:04:14
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.De către Timmerman Report
…
continue reading
1
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
1:02:42
1:02:42
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:02:42
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.De către Timmerman Report
…
continue reading
1
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
1:08:08
1:08:08
Redă mai târziu
Redă mai târziu
Liste
Like
Plăcut
1:08:08
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.De către Timmerman Report
…
continue reading